Diaverum grows its presence in Brazil by acquiring a new clinic in São Paulo

São Paulo, August 30, 2019 – Diaverum, one of the world’s leading renal service providers, extends its services to São Paulo city through the acquisition of CNTT – Clínica de Nefrologia e Transplantes do Tatuapé. With this addition, Diaverum now operates 6 treatment centers, treating more than 2400 patients in Brazil. 

Diaverum is pleased to announce its expansion into São Paulo municipality, the most populous city and largest economy in Latin America, by acquiring CNTT – Clinic de Nefrologia e Transplantes do Tatuapé, a high-quality renal care center founded by Dr. Elias David Neto, one of the most renowned nephrologists in Brazil.

"This acquisition is aligned with our strategy to consolidate Diaverum’s position in selected markets with a strong potential for continued growth. By partnering with high-standard treatment centers we also reinforce our mission to provide life enhancing renal care to patients around the world,” commented Boris Zjacic, Chief Operational Officer at Diaverum. 

“We are very pleased to welcome Dr. Elias and his team into the Diaverum family. Based on our shared vision, we will work together to deliver world-class renal care to our patients and enable them to live fulfilling lives. Now our focus will be on integrating CNTT into our organization while we exchange best practices and plan for further expansion of our services,” adds Rafael Romanini, Country Manager Brazil, Diaverum. 

Brazil media contact:
Mr. Rafael Ferreira, Communications, Diaverum Brazil
E-mail: Rafael.ferreira@diaverum.com 
Contact: +55 11976494027

Ms Joanna Borczak, Director Global Marketing, Diaverum
E-mail: joanna.borczak@diaverum.com

Contact: +48 532 793 882

Diaverum is a global renal care provider with a clear patient focus. As one of the world’s leading renal care providers we stand for excellent medical quality, renal care services and a patient-centered research. Being product-independent also gives us the flexibility to offer individual treatments for the individual needs of our patients and by coordinating our patients’ healthcare needs, we are improving their quality of life. At the same time, we are creating value in the healthcare system by optimising the use of healthcare budgets — for the benefit of the patient and the society. Our experience in renal care dates back more than 25 years, when the first dialysis clinic was established, under the former name Gambro Healthcare, defining our Swedish roots. Today 11,000 employees care for more than 36,000 patients in 20 countries in Europe, South America, Asia and Africa. Diaverum has its head office in Malmö, Sweden. www.diaverum.com


About Us

Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe, and we help some 39,000 patients with 6 million treatments annually. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services. CKD is a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries. CKD disproportionately affects low income individuals and we ensure that our clinics are a safe and familiar space where all our patients are made to feel welcome. Diaverum’s vision is to transform renal care, to offer the highest quality of care and empower patients to live a fulfilling life. We work together with payers to reduce total cost of care while partnering with local communities to educate around health and the value of prevention. At the centre of what we do is our standardised, proprietary care delivery model, enabled by a continuously evolving digital infrastructure. We strive to ensure superior medical outcomes exceeding those demanded by national healthcare systems and we support patients by improving personalized care, ease of use and new services through technology. Diaverum employs more than 11,000 employees and operates more than 420 clinics in 22 countries globally. Diaverum has its head office in Malmö, Sweden. http://www.diaverum.com/